Report
Valens Research

UAFRS vs As Reported Weekly Highlights - Asia - 2020 11 13

This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for 065130:KOR, 2427:JPN, and 3692:HKG.
Underlyings
Hansoh Pharmaceutical Group Company Limited

HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED is a China-based investment holding company principally involved in the the research and development, production and sale of pharmaceutical products. The Company's main products include Oulanning, Ameining, Pulaile, Zefei, Xinwei, Xinmei, Zetan, Mailingda, Hengjie, Hengsen, Fulaidi and Ruibote, among others. The Company's products are mainly used for central nervous system disease, oncology, anti-infection, diabetes, digestive tract and cardiovascular treatment. The Company distributes its products in domestic market.

OUTSOURCING Inc.

Outsourcing is mainly engaged in the provision of integrated outsourcing services with focus on production and administrative operations. Co. operates in seven business segments: Domestic Engineering Outsourcing, Domestic Manufacturing Outsourcing, Domestic Service Operations Outsourcing, Domestic Administrative Outsourcing, Domestic Recruiting and Placing, Overseas Engineering Outsourcing, Overseas Manufacturing and Service Operations Outsourcing. Co. provides outsourcing services for production, engineering, manufacturing, IT operation, administrative operation, and recruitment in Japan as well as Asia, South America, Europe and Australia.

Top Engineering Co. Ltd.

Top Engineering Company Limited. Top Engineering Co., Ltd. is a Korea-based company engaged in the manufacture of semiconductor and display equipment. It provides liquid crystal display (LCD) equipment including liquid crystal (LC) dispensers, sealant (SEAL) dispensers, gas cutting systems (GCSs), array testers, in-line systems and wet cleaning equipment; light emitting diode (LED) equipment including inductively coupled plasma (ICP) etchers, low temperature plasma chemical vapor depositions (CVDs) and LED dispensers; semiconductor equipment including flip chip bonders, potting systems and marking systems; organic light emitting diode (OLED) equipment, such as OLED seal dispensers, and central chemical supply systems. On December 12, 2013, it sold a certain shares of IM Tech Inc. On March 5, 2014, it merged with a wholly owned subsidiary, engaged in the manufacture and distribution of displayer and semiconductor testers.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch